HCW Biologics Inc.

NasdaqCM:HCWB Stock Report

Market Cap: US$8.6m

HCW Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HCWB?
Owner TypeNumber of SharesOwnership Percentage
Institutions75,3016.7%
Hedge Funds167,92514.9%
General Public428,41338.1%
Individual Insiders451,71440.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.8%.

Top Shareholders

Top 25 shareholders own 61.83% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.5%
Hing Wong
298,163US$2.3m-25.7%no data
15%
Armistice Capital LLC
167,925US$1.3m232%0.03%
9.19%
Yau Bee
103,190US$787.6k0%no data
4.24%
Axone Capital
47,619US$363.5k0%no data
3.08%
Rebecca Byam
34,548US$263.7k0%no data
0.62%
Avantax Planning Partners, Inc.
6,988US$53.3k0%no data
0.6%
Scott Garrett
6,696US$51.1k0%no data
0.42%
Lee Flowers
4,756US$36.3k0%no data
0.4%
Geode Capital Management, LLC
4,548US$34.7k-0.72%no data
0.4%
HighTower Advisors, LLC
4,520US$34.5k0%no data
0.29%
Cresset Asset Management, LLC
3,299US$25.2k0%no data
0.17%
Peter Rhode
1,938US$14.8k0%no data
0.17%
Pullen Investment Management, LLC
1,877US$14.3k0%0.01%
0.098%
Richard Greene
1,103US$8.4k0%no data
0.094%
BlackRock, Inc.
1,054US$8.0k-1.86%no data
0.084%
The Vanguard Group, Inc.
941US$7.2k0%no data
0.08%
Lisa Giles
895US$6.8k0%no data
0.077%
Bridgeway Capital Management, LLC
867US$6.6k-59.1%no data
0.076%
XTX Holdings Limited, Asset Management Arm
849US$6.5k0%no data
0.067%
AE Wealth Management, LLC
750US$5.7k0%no data
0.048%
State Street Global Advisors, Inc.
536US$4.1k0%no data
0.038%
Gary Winer
425US$3.2k0%no data
0.035%
Virtu Financial LLC, Asset Management Arm
390US$3.0k0%no data
0.033%
Renaissance Technologies LLC
375US$2.9k0%no data
0.027%
Two Sigma Investments, LP
302US$2.3k-46.2%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/05 09:40
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HCW Biologics Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael OkunewitchMaxim Group